Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,329 public trials 916 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Terminated

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

NCT06882746

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +13 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View Trial Details
Terminated

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

NCT04844073

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +30 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado - Anschutz Medical Campus - PPDS Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Terminated

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

NCT06039384

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Banner Md Anderson Cancer Center Greeley, Colorado, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Mary Crowley Cancer Research Centers McCrc Headquarters Dallas, Texas, United States
View all 14 locations
View Trial Details
Terminated

Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer

NCT05167409

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Rutgers Cancer insititute New Brunswick, New Jersey, United States
  • Inova Schar Cancer Institute Fairfax, Virginia, United States
View Trial Details
Terminated

A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

NCT05328908

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +18 more
Locations
  • Local Institution - 0044 Springdale, Arkansas, United States
  • Local Institution - 0012 Los Angeles, California, United States
  • Local Institution - 0117 Norwich, Connecticut, United States
  • Local Institution - 0025 Miami, Florida, United States
View all 139 locations
View Trial Details

Related conditions